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Abstract
Background: Membranes play a crucial role in cellular functions. Membranes provide a physical barrier, control the
trafficking of substances entering and leaving the cell, and are a major determinant of cellular ultra-structure. In
addition, components embedded within the membrane participate in cell signaling, energy transduction, and other
critical cellular functions. All these processes must share the limited space in the membrane; thus it represents a
notable constraint on cellular functions. Membrane- and location-based processes have not yet been reconstructed
and explicitly integrated into genome-scale models.
Results: The recent genome-scale model of metabolism and protein expression in Escherichia coli (called a ME-model)
computes the complete composition of the proteome required to perform whole cell functions. Here we expand the
ME-model to include (1) a reconstruction of protein translocation pathways, (2) assignment of all cellular proteins to
one of four compartments (cytoplasm, inner membrane, periplasm, and outer membrane) and a translocation pathway,
(3) experimentally determined translocase catalytic and porin diffusion rates, and (4) a novel membrane constraint that
reflects cell morphology. Comparison of computations performed with this expanded ME-model, named iJL1678-ME,
against available experimental data reveals that the model accurately describes translocation pathway expression and
the functional proteome by compartmentalized mass.
Conclusion: iJL1678-ME enables the computation of cellular phenotypes through an integrated computation of
proteome composition, abundance, and activity in four cellular compartments (cytoplasm, periplasm, inner and
outer membrane). Reconstruction and validation of the model has demonstrated that the iJL1678-ME is capable
of capturing the functional content of membranes, cellular compartment-specific composition, and that it can be
utilized to examine the effect of perturbing an expanded set of network components. iJL1678-ME takes a notable
step towards the inclusion of cellular ultra-structure in genome-scale models.
Keywords: Constraint-based modeling, gene expression, metabolism, protein translocation, compartmentalization
Background
Compartmentalization provided by membranes is essen-
tial for life. Compartmentalization allows unique internal
microenvironments, permits harvestable energy gradi-
ents, provides organizational structure, protects the cell,
and more. Membranes also represent significant physical
barriers. Thus, cells have evolved pathways that allow
molecule transport between compartments. As a gram-
negative bacterium, Escherichia coli has two membranes:
An inner, tightly regulated membrane and an outer, more
porous membrane (see [1,2] for review). In order to
achieve desired membrane functions, E. coli has evolved a
system to translocate proteins into their appropriate
locations.
There is a wealth of scientific information on protein
translocation processes, but holistic studies on their
system-wide effects are lacking. Such genome-wide studies
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are important as protein translocation enables key cellular
functions. These functions need to be put into context of
all other cellular functions to understand their energetic
requirements, general interactions and balance with the
rest of the cell. To do so, one must take a systems
approach, where comprehensive molecular processes and
interactions are reconstructed into a self-consistent and
computable format. A couple of recently published studies
have taken steps in this direction. In a comprehensive
approach to cellular processes, the recent whole-cell
model of Mycoplasma genitalium incorporates a SecA +
Sec translocase pathway into one of its protein formation
modules [3]. In this model, translation is uncoupled from
translocation, even though the two processes can happen
concurrently [4]. Furthermore, protein translocation rates
are not calculated de novo but are instead based on user-
inputted gene expression levels and energy-carrier metab-
olite concentrations (calculated prior from a separate
module). Thus, set expression levels of protein translo-
cases operate as a constraint on other processes; for ex-
ample, metabolism uptake is dependent on the number of
transporters. Additionally, membrane lipid formation is
driven by a biomass objective function [3], whereas a com-
putation based on a cell’s surface area might be more
appropriate. In another study, a larger effort was focused
on the genome-scale reconstruction of the protein secre-
tion pathway in Saccharomyces cerevisiae [5]. This model
of protein secretion is ‘stand-alone’ and is not integrated
with additional cellular processes. It can be used as a scaf-
fold on which omics data (e.g., RNA-seq) can be overlaid
to estimate effects of protein abundance and metabolic
costs of translocation on the cell. Although these models
contain some detail about protein translocation, both are
reliant on expression data input and are not dependent on
the demands of cellular events. Finally, another notable
model incorporated membrane space into a genome-scale
model of E. coli to demonstrate that while the membrane
may cap certain fluxes, leading to simultaneous respiration
and fermentation at high growth rates, metabolic demands
drive the membrane proteome. Although this model lacks
the process of protein translocation and has only four in-
tegral proteins, it demonstrated that the consequence of
protein translocation, namely compartment formation,
truly constrains cellular events [6].
A recent genome-scale model of metabolism and
gene-expression of E. coli, called a ME-model [7] or spe-
cifically, the retroactively named iOL1650-ME model
(following a previous naming convention [8]), affords us
the opportunity to integrate protein translocation seam-
lessly with cellular processes. Although iOL1650-ME de-
scribes the synthesis of all the proteins in the proteome,
the proteins are not compartmentalized. In this work,
we significantly expanded the validated iOL1650-ME
model [7] to include a comprehensive reconstruction of
protein translocation pathways. The expanded iOL1650-
ME includes a reconstruction of lipoprotein biogenesis,
the incorporation of four distinct protein compartments
(cytoplasm, periplasm, the inner and the outer mem-
brane), published enzymatic rates of the translocases and
diffusion rates of outer membrane porins, and a mem-
brane constraint based on cell morphology all integrated
into one reconstruction. The expanded model, hereafter
referred to as iJL1678-ME, allows for de novo prediction
of enzyme abundances and their cellular location as well
as the constraining effects of membrane production. We
apply iJL1678-ME to show how it is predictive of com-
partmentalized cellular content for validation, describe its
utility and limitations, and show how it can be applied to
examine a broadened scope of applications including
targeted inhibition of proteins.
Results and discussion
All proteins in E. coli are synthesized in the cytoplasm,
but over 20% of E. coli’s protein-coding open reading
frame (pORF) are annotated to encode protein with
non-cytoplasmic functions, and an estimated 15% of
cellular protein mass is in the cell envelope [9,10]. These
proteins are assisted by translocase complexes to get to
their cellular destinations. Depending on their final loca-
tion and biochemical properties, the translocation route
taken for a particular protein involves one of three integral
inner membrane translocases (Sec, Tat, and YidC) and
perhaps an outer membrane translocase (LolB and Bam)
(see [1,11] for review). The most-studied and ubiquitous
translocase is the Sec complex [12]. The channel-forming
Sec protein has two chaperone pathways that converge on
it. One, the SRP/Sec pathway, brings nascent peptides to
the Sec complex and primarily uses the kinetic energy of
translation to drive protein integration into the inner
membrane [4,13,14]. Sometimes, the mediator YidC binds
to Sec complex to enhance proper membrane integration,
but on its own, YidC is an insertase that translocates a
couple of essential proteins [15-17]. Alternatively, proteins
moving to the periplasm and beyond generally follow the
SecB/Sec pathway which uses an ATPase, SecA, to thread
chaperoned, unfolded proteins through the Sec complex
and into the periplasm [18-21]. Furthermore, non-
cytoplasmic, folded proteins which often contain cofactors
take the Tat translocase, a dynamic protein complex that
recruits TatA subunits to adjust its channel size appropri-
ately and is driven by an electrochemical gradient [22-24].
To get to the outer membrane, proteins must first cross
the inner membrane, then take one of the two pathways:
Lol or Bam. The Lol pathway excises lipoproteins from
the inner membrane and incorporate them into the outer
membrane [25,26]. In the Bam pathway, unfolded β-
barrels are chaperoned in the periplasm, typically by SurA
[27,28], to the Bam complex, which facilitates their proper
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insertion into the outer membrane [29]. Alterations to
these pathways exist, but these five translocation pathways
are thought of as canonical pathways [25,30]. All this
information enables a bottom-up reconstruction of the
protein translocation network in E. coli.
Reconstruction of protein translocation processes and
their incorporation into iOL1650-ME
A bottom-up procedure to reconstruct the network of pro-
tein translocation and lipoprotein biogenesis within a
genome-scale model of metabolism and gene-expression in
E. coli [7] was developed (Figure 1A). The result of imple-
menting this procedure was a biochemically, genetically,
and genomically structured network [31] that enabled the
analysis of the molecular effects of protein translocation in
context of other networks using constraint-based analysis
methods. The network reconstruction procedure involved
five major phases.
Reconstruction of protein translocation pathways
Through an extensive literature search, the SecB/Sec,
SRP/Sec, Tat, Lol, Bam, and YidC insertion translocation
pathways were identified for inclusion into the reconstruc-
tion (Figure 1B) (see [1,11] for review). Three additional
pathways were also included, based on case studies
demonstrating that the SRP/Sec pathway occasionally
requires assistance from YidC and/or SecA to have prop-
erly formed integral proteins [25,30,32]. In addition to
protein translocation, lipoprotein biogenesis pathways
were reconstructed, as lipoproteins are located in mem-
branes and are essential through their structural and func-
tional uses (Methods & Additional file 1) [33-35]. In the
end, 27 pORFs and one RNA gene, which together form
16 protein complexes, were added to the model to enable
protein translocation (Additional file 2: Tables S1 and
S2). Furthermore, based on the sequence of events in
each of these pathways, a set of mechanistic reactions
(i.e., template reactions [36]) were developed that could
be applied to and individualized for every pORF
(Additional file 1).
Compartmentalization
The incorporation of protein translocation pathways
requires proteins to have defined compartmentalization.
First, two new compartments, inner and outer membranes,
were added to the three existing compartments in
iOL1650-ME (cytoplasm, periplasm, and extra-cellular) [7].
Using the protein databases EchoLocation [37], Uniprot
[38], and Ecocyc [39] as well as the bioinformatic programs
PSORTb [40] and TMHMM [9], the 1,568 pORFs included
in the reconstruction were assigned to compartments
(Figure 1C). pORFs with a transmembrane component or
a lipid membrane anchor were assigned to either the inner
or outer membrane; otherwise, pORFs were either
cytoplasmic or periplasmic. Proteins composed of multiple
pORFs were assigned to the compartment of its compo-
nents (Additional file 2: Table S2), but if any of its pORFs
was in a membrane then the entire complex was assigned
to that membrane, with the outer membrane taking prece-
dent over the inner (e.g., AcrAB-TolC multidrug efflux
system is assigned to the outer membrane). For example,
ATP synthase has pORFs located in the inner membrane
(AtpB, AtpC, AtpE, AtpF) and cytoplasm (AtpA, AtpD,
AtpG, AtpH), but the synthase itself is assigned to the
inner membrane so that it may interact with metabolites in
both the cytoplasm and periplasm.
The compartment assignment resulted in 71% of
pORFs being assigned to the cytoplasm, 21% to the
inner membrane, 6% to the periplasm, and 2% to the
outer membrane.
Assigning translocated proteins to pathways
Protein translocation reactions were formulated for each
pORF. Using a set of rules based on experimental data, pro-
tein location, and physical properties (Additional file 2:
Table S3), non-cytoplasmic annotated pORFs were assigned
to translocation pathways (Figure 1D). The developed
template reactions allowed for the methodological creation
of each pORF’s translocation reactions and their subsequent
incorporation into the reconstruction. Additional pathway
development steps included determining the amount of
ATP hydrolyzed by SecA for each pORF (i.e., 1 ATP per
~25 amino acids) [41], assigning 23 pORFs to lipoprotein
biogenesis [37], and calculating the number of TatA’s nee-
ded for each Tat-translocated pORF [23] (Additional file 1,
Additional file 2: Table S1, Additional file 3: Figure S1).
Published translocase kcat values were associated with
appropriate proteins in the translocation pathways.
(See figure on previous page.)
Figure 1 The workflow utilized and resulting network for reconstructing protein translocation in E. coli. (A) An outline of the workflow
used to reconstruct the protein translocation network in E. coli. At each step, various sources of data were used as inputs to the workflow. The resulting
general network, compartmentalized content, and pathway breakdown are shown in greater detail to the right. (B) A diagram of the translocation
pathways included in the reconstruction: SRP/Sec, SecB/Sec, Tat, YidC, Lol, Bam pathways, and three alternatives (dashed lines). Proteins that allow
translocation are labeled in white while translocated protein types are labeled in black. Lipoprotein biogenesis is not depicted. (C) Model-simulated
pORFs were assigned to one of four compartments. The numbers denote how many of the 1,568 proteins will end up in each compartment. (D) Each
non-cytosolic pORF was assigned to a translocation pathway. Numbers in white are how many pORFs require that translocation-associated protein. The
model also underwent several other updates, including the addition of known turnover rates that are denoted by black numbers.
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These values [42-46] were incorporated into the model
through coupling constraints [36,47], which account for
turnover rates by linking gene expression to metabolism
through the dependence of reaction fluxes on enzyme
concentration (Figure 1D) [35]. Additionally, outer mem-
brane porins were represented to behave as passive-
diffusion channels [2] in the reconstruction. Instead of
identical turnover rates for all outer membrane porins in
the cell, incorporation of porin-specific coupling con-
straints allowed the model to account for individualized
solute diffusion rates based on effective porin radius,
hydrodynamic solute radius, membrane thickness, and
growth rate (see Additional file 2: Table S4 for list of sol-
utes, which are also exchange metabolites). This formula-
tion represents the cross-sectional area a solute can pass
through and distance a solute had to travel to reach the
periplasm [48] (Additional file 1). Without these coupling
constraint updates, the model was unable to predict
accurate translocase levels (Additional file 3: Figure S2).
Incorporating cell-size and membrane constraints
Cell envelope production was fundamentally changed
to reflect the cell’s shape and composition more accur-
ately. The previously-developed iOL1650-ME accounts
for production of kdo 2 lipid IV, phospholipids, and
murein through growth rate dependent demands scaled
to cell size [7]. These demands were identified as key
areas for improvement to a more mechanistic descrip-
tion in iJL1678-ME. Changes to the model included
adding murein recycling, a lipoprotein demand, and a
membrane spatial constraint. The peptidoglycan layer
protects the cell from lysis by providing a physical
structure, and it also dynamically renews its components
by using enzymes located in all compartments of the cell
(see [49] for review). To reflect this renewal process,
AmpG permease transports anhydro-muropeptides to
equal 45% of the murein demand, which causes a murein
recycling loop [50]. Lipoproteins are also important for
structural integrity, and the number of lipoproteins that
have been estimated in a cell, 7×105, is a significant
amount of mass [10], so a growth-rate scalable lipoprotein
demand, using Braun’s lipoprotein [51], was added. Finally,
because there are inner and outer membrane compart-
ments, membrane demands and composition can be
more explicitly described with the genome-scale model.
Membrane surface area, which is a function of growth
rate, is required to be occupied completely by proteins
and lipids (see Methods). The surface area of integral
proteins was calculated from their mass, except for li-
poproteins which were set to the approximate cross-
sectional area of their lipid moieties (Additional file 2:
Table S5) [10,23,52]. The rest of the outer membrane
outer leaflet is filled in with kdo 2 lipid IV while the
other three membrane leaflets are occupied by a mixed
composition of phospholipids (see Methods for math-
ematical formulation of the membrane constraint)
[53,54]. This novel membrane constraint not only al-
lows a variable membrane proteome, but it also ensures
that the cell is completely covered by two membranes.
Updating model parameters
Two model parameters were updated to reflect the new re-
construction content. The growth-associated maintenance
(GAM) was updated from 35 to 34.98 mmol ATP gDW−1
to account for the ATP spent translocating proteins out of
the cytoplasm, which is small compared to the cell’s total
energy production but expensive per non-cytoplasmic pro-
tein (0.02 for translocating 2.3×10-3 mmol protein gDW−1,
or 85.7 ATP for each non-cytoplasmic protein). Also, the
out-of-scope protein proportion of proteome, a parameter
introduced in iOL1650-ME to account for proteins
expressed in vivo but not actively utilized by the network
reconstruction [7,55], was changed. As iJL1678-ME in-
cludes more pORFs, this parameter’s value had to be
reduced by the expressed mass of new protein content.
Thus, the out-of-scope protein proportion was changed
from 0.45 to 0.36 to reflect iJL1678-ME’s increased
comprehensiveness.
Taken in whole, the improved network reconstruction
demonstrated that there is enough scientific literature to
accurately reconstruct protein translocation in a genome-
scale model. As a result of having this reconstruction, it
was possible to compute physiological aspects of the cell
envelope, which converges to a fully comprehensive in
silico model of E. coli (Additional file 4).
Proteomic shifts highlight the significance of new content
in iJL1678-ME
iOL1650-ME and iJL1678-ME enable quantitative pre-
dictions of genome-scale proteome abundances. Instead
of requiring input expression data, these models calcu-
late the proteins necessary to maximize growth rate
through a metabolism-centered network. However, not
only does iJL1678-ME contain more reconstructed
content, but it also has a reformulated cell envelope
representation that requires more membrane produc-
tion, phospholipid variety, and murein recycling.
To demonstrate the difference between the two ME-
models, the computed protein expression fluxes in glucose
M9 minimal media were compared (Figure 2, in silico
media composition given in Additional file 2: Table S6).
Although the majority of pORFs (1475) were approxi-
mately the same in both model simulations, 32 of the
genes were differentially expressed, and a number of
proteins were uniquely expressed (Figure 2A). Clearly,
accommodating protein translocation has a systemic effect
on the computed proteome.
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Looking first at pORFs expressed in both models, the
largest outlying subgroup is the cell membrane and enve-
lope related proteins. This differential expression was due
to the addition of murein recycling, which increases
overall murein production (145%) and associated ATP
expenditure (140%, which is 2.3% of all ATP production in
iJL1678-ME). It has been previously reported that murein
recycling can come as a significant cost to the cell [50]. As
for carbohydrate metabolism, the porin coupling con-
straint forced iJL1678-ME to consider the slower diffusion
rate of acetate verses gaseous molecules; thus, iJL1678-
ME utilized acetate overflow (i.e., fermentation) pathways
less than iOL1650-ME. Not only was its acetate secretion
less (1.5 verses 8.1 mmol gDW−1 h−1), but it also down-
regulated two genes involved in small carbon molecule
metabolism (eutD and purT). Instead, iJL1678-ME ad-
justed its energy production pathways so that more of its
ATP was generated through oxidative phosphorylation. As
a consequence, expression of TCA cycle proteins and suc-
cinate dehydrogenase was greater. Finally, the collective
increase in protein expression due to the expanded scope
of iJL1678-ME led to greater expression of transcription,
vitamin B12 transporters, and nucleotide metabolism
proteins.
When examining the uniquely expressed genes, 65
genes were unique to iJL1678-ME (Figure 2B), and 6 to
iOL1650-ME. Of the uniquely expressed pORFs in
iJL1678-ME, 42% were reconstructed in this paper and
thus not contained in iOL1650-ME. The rest were due to
murein recycling, more phospholipid variety (as part of the
membrane constraint), and an increase in oxidative phos-
phorylation, which in turn required heme metabolism. As
for the uniquely expressed proteins in iOL1650-ME, these
proteins were due to isozymes employed (e.g., AcnA verses
AcnB in iJL1678-ME).
In summary, the increased scope of modeled genes in
iJL1678-ME caused a notable change in protein expres-
sion levels, and these shifts can be directly attributed to
model updates and constraints derived from biochemical
knowledge available in literature. The resulting proteomic
content was examined further.
In silico computations recapitulate in vivo data
To estimate the accuracy of the iJL1678-ME in silico
proteome, glucose M9 minimal media simulation re-
sults were compared to experimental data (Additional
file 2: Table S6). Unlike iOL1650-ME, iJL1678-ME cal-
culates a compartment-specific proteome with absolute
protein levels. Although this ability may be especially
useful in studying the membrane proteome, an area pla-
gued by hardship due to its hydrophobic and amphiphilic
nature, it has also created difficulty in comprehensively
−30
−25
−20
−15
−10
−30 −25 −20 −15 −10
iOL1650−ME
protein translation flux log(mmol gDW   h  )
iJ
L1
67
8−
M
E
pr
ot
ei
n 
tra
ns
la
tio
n 
flu
x 
lo
g(m
mo
l g
DW
   h
  )
0
10
20
Am
in
o 
Ac
id
Ca
rb
oh
yd
ra
te
Ce
ll M
em
b r
a
n
e
s 
& 
E n
ve
lo
pe
Co
fa
ct
or
 &
 
Pr
os
th
et
ic
 G
ro
up
In
or
ga
ni
c 
Io
n
Pr
ot
ei
n 
Tr
a
n
sl
oc
at
io
n
Tr
a
n
sp
o r
t
uniquely expressed genes in iJL1678-ME
co
u
n
t
A)
B)
Function
Carbohydrate Metabolism
Cell Membranes & Envelope
Oxidative 
Phosphorylation
Transcription
Transport
Nucleotide Metabolism
-inf
-inf
TCA
murein
sigma factors
small carbon
metabolite
-
1
-
1
-1-1
vitamin B12
Genes in both models
New genes in iJL1678-ME
Inorganic Ion
Other
Figure 2 Proteome expression comparison between iOL1650-ME and iJL1678-ME. The difference that the protein translocation
reconstruction brings to iOL1650-ME is compared through computed protein expression in glucose M9 minimal media conditions. (A) Protein
translation flux between iJL1678-ME and iOL1650-ME. The majority of pORF expression (93.5%) are approximately the same in both model
simulations, but 4.1% are uniquely expressed in iJL1678-ME, and 0.4% is uniquely expressed in iOL1650-ME (points along the -inf line). 2.0% of the
proteins are differentially expressed, the majority of which are expressed to a greater extent in iJL1678-ME than in iOL1650-ME, but two proteins
involved in small carbon metabolism (EutD and PurT) are expressed lower. (B) Histograms detailing the functional annotations of the uniquely
expressed genes within the two models.
Liu et al. BMC Systems Biology 2014, 8:110 Page 6 of 15
http://www.biomedcentral.com/1752-0509/8/110
evaluating iJL1678-ME’s results. Even though the cor-
relation between the transcriptome and proteome is
poor on a protein-to-transcript level [56,57], RNA-seq
is a robust currently-available omic data-source which
covers genome-scale expression in all compartments.
Assuming that discrepancies in transcript-to-protein
ratios are reduced through averaging, RNA-seq data
(GEO accessions: GSE48324 [58] and GSE61327 [59])
was assumed as a one-to-one proxy for protein levels.
Protein masses were calculated from amino acid se-
quences and normalized by relative fractional proteome
mass. Once a comprehensive quantitative proteomics
dataset is available, it will be important to validate that
the same functional groups are under-predicted.
Since the network reconstruction expanded the scope of
iOL1650-ME, we sought to validate the new features of the
genome-scale model. The computed mass of all proteins
associated with a translocation pathway (color labeled in
Figure 1B) as a fraction of total cellular protein mass is
largely similar to in vivo data (Figure 3A, Additional file 3:
Figure S3). The most notable outlier is the Tat pathway.
The difference between in silico and in vivo expression
may be due to the fact that a TatBC complex forms
multiple channels to simultaneously translocate substrates
[60,61], but in iJL1678-ME model, each TatBC complex
translocates a single substrate at any point in time. To ex-
plore the possibility of a different representation for TatBC,
the mass of TatBC was adjusted by four-fold (the maximum
demonstrated number of bound precursor proteins) and
this improved the in vivo to in silico correlation (R2 = 0.897
to 0.925, p-value = 0.014 to 0.009), which hints at the possi-
bility TatBC commonly forms multiple channels per com-
plex in vivo. These results demonstrate that bottom-up
reconstruction approaches and constraint-based modeling
can estimate relative protein levels when incorporated with
turnover rates and metabolic demands and serves as valid-
ation of the reconstructed content (see Additional file 3:
Figure S2 for translocation without kcat).
iJL1678-ME’s ability to accurately compute protein
amounts extends to compartmentalization, which is
enabled due to protein translocation (Figure 3B). Simula-
tion results predict that the mass of cytoplasmic proteins
constitute approximately 79% of the proteome, while the
inner membrane protein masses are 10%, periplasmic
1.0%, and outer membrane 10%. Calculating these same
values for in vivo measurements gave 76.6%, 10.6%, 4.9%,
and 7.9%, respectively. In a complementary analysis,
iJL1678-ME estimated outer membrane protein values
closer to published numbers than in vivo (RNA-seq) data’s
approximation of the outer membrane proteome. The in
silico protein numbers reflect experimental published
amounts at 7.2×105 lipoproteins verses 7×105 and
1.5×105 porins verses 2×105 [10], which implies that the
RNA-to-protein ratio is not one-to-one for outer mem-
brane proteins. As there are less proteins in the non-
cytosolic compartments, the averaging effect of large
groups is less effective, which may explain the discrepancy.
Where do the similarities and differences between the
computed and measured compartment-specific protein
mass arise from? To answer this question, the protein
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masses were broken down into smaller subgroups, as la-
beled in iJO1366 which used EcoCyc and GO annotations
[39,62]. All 1,568 pORFs were categorized by functional
annotation as opposed to a gene-by-gene comparison, with
the assumption that a larger sample size would reduce the
discrepancies between protein and RNA abundances. A
comparison between computational predictions and ex-
perimental data was performed using linear regression of
log-log values with zero values being removed from fur-
ther calculations (Figure 4). A normal probability plot of
the standardized residuals of the initial model (Additional
file 3: Figure S4) revealed that while most points could be
described by a normal distribution, five points describing
lowly-expressed functions in iJL1678-ME were out of
range (Figure 4A). These five points were separated for
further analysis while the reduced set of points was refit-
ted, resulting in a more accurate linear model (Figure 4B).
Due to their departure from normalcy, the five out-
liers in Figure 4A were examined to identify reasons for
modeled discrepancies. The five points covered genes
involved with inorganic ions, cofactor and prosthetic
groups, protein maturation, and metabolite transporta-
tion. Not only is the available knowledge of metal ion
and cofactor requirements sparse [63], but the model
demands the incorporation of only the most necessary
groups into proteins. As result, expression of inorganic
ion, cofactor, and prosthetic related pORFs are low.
Similarly, protein maturation pORFs are required for
proper inclusion of ions and groups; they also assist
mis-folded proteins, whose possibility are not com-
puted in optimal situations. Lastly, iJL1678-ME predicts
a lower periplasmic mass for small metabolite transpor-
tation as compared to in vivo data. Closer examination
of this functional group revealed that the model has
severely decreased the diversity of ABC transporters to
five protein species. However, E. coli produces multiple
species of ABC transporters in preparation for environ-
mental changes [64]. This readiness to consume a
variety of substrates improves the cell’s overall fitness,
but when confronted with glucose as the sole carbon
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Figure 4 Analysis of in silico predicted protein masses verses in vivo measurements. Predicted (in silico) versus measured (in vivo) protein
masses that were reconstructed in iJL1678-ME were categorized by function and compartment. Subgroups with zero values were removed from
further calculations. (A) The linear model between in silico and in vivo protein mass predictions (p-value = 6.6x10−3). The outliers had standardized
residues that fell outside of the normal distribution curve as formed by the other points (Additional file 2: Figure S4). (B) The outliers were
removed, and the linear model between in silico and in vivo protein mass predictions was recalculated (p-value = 6.6x10−6).
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substrate, the varied over-expression limited the pre-
dicted optimal growth rate, according to iJL1678-ME.
Applications predict the effect of molecular perturbations
Genome-scale models of metabolism have enjoyed many
successes in elucidating interactions, metabolic engineer-
ing, drug targeting, and more. Up to this point in time,
perturbations in genome-scale models are often focused
on gene knockouts and constraining a particular reaction
to a bound [65]. iJL1678-ME can be used to provide new
insights which cannot be currently be achieved with exist-
ing models; that is, iJL1678-ME can be used to estimate
the detailed effects of molecular processes and physical
parameters and on a much broader scale. This ability of
iJL1678-ME will be demonstrated through two examples:
Membrane crowding and Sec pathway inhibition.
Assessing the consequences of membrane crowding
Molecular crowding in the finite space of cells limits
metabolic activity [6,66]. Such crowding constraints are
found both in the volume of the cell (also called ‘packing’
constraints) as well as the surface area of its membranes.
iOL1650-ME, and consequently iJL1678-ME, implicitly
considers volume crowding effects because density is con-
strained based on the overall growth rate [7]. Limited
surface area in the membranes are thought to constrain
major aspects of metabolism and physiology; for example,
it may force E. coli to employ a mixture of respiration and
fermentation to maximize growth rate [6,67]. Thus, as
part of the reconstruction process, a constraint on the
fraction of protein in the membranes was incorporated
into iJL1678-ME (Additional file 1). This membrane con-
straint is mechanistic and imposed on a genome-scale,
thereby representing a unique opportunity for a detailed
assessment of the consequences of limited membrane
space. The results of restricting the total surface area of
integral membrane proteins in the model are described.
Computations of growth optimization were performed
with constraints on the protein-to-lipid surface area ratios
in both the inner and outer membranes. These computa-
tions revealed that the maximum growth rate was achieved
when the fraction of membrane surface area occupied by
protein was 42% and 25% for the inner membrane and
outer membrane, respectively. Furthermore, over- and
under- production of membrane proteins did not affect the
maximum growth rate with the same severity. The uneven
slopes from the apex at 42% and 25% indicates that over-
expression of membrane proteins may be less taxing on
growth rate than under-expression, suggesting that it may
in the cell’s favor to over-produce membrane proteins than
under-produce (Figure 5A).
As the inner membrane contains a diverse set of pro-
teins that are important for metabolism, iJL1678-ME
was used to examine the effects of spatial limitations on
the inner membrane proteome. Although oxidative phos-
phorylation is much more efficient than alternate energy
producing pathways, E. coli at high growth-rates and in
excess glucose also employs fermentation pathways [68].
The electron transport system (ETS) is embedded in the
membrane, and limited membrane space for the ETS may
be why E. coli resorts to the mixed energy-production
strategy [6]. iOL1650-ME, on the other hand, predicted
that such a phenomenon occurs based on the trade-off
between ATP generation and protein production costs [7].
In iJL1678-ME, acetate secretion has been almost
eliminated compared to iOL1650-ME (8.1 to 1.5 mmol
gDW−1 h−1), due to the porin constraint. Differences in
diffusion rates for each metabolite allowed the model to
recognize that gases diffuse faster than solubilized car-
bon molecules, and complete metabolism of a carbon
source becomes a better investment. However, fermen-
tation returned when the inner membrane protein
surface area decreased below 50%, as demonstrated by
the increased secretion of acetate (Figure 5B). Within
these regions of constraining protein-occupied surface
area, the cell model produced less oxidative phosphor-
ylation products, which includes the ETS, instead of
glucose PTS permeases and transporters for continued
and increased glucose uptake, as previously hypothe-
sized (Figure 5B & C) [6]. At extremely low surface
areas allocated to proteins (≤10%), there was not
enough room to accommodate NADH dehydrogenase in
the membrane. Instead, alternate dehydrogenases were
expressed. Thus, to maximize growth rate, iJL1678-ME
choses to increase fermentation rates with decreased
membrane space.
Once membrane space permits complete metabolism of
glucose influx at ~50% protein-occupied surface area, fer-
mentation pathways are no longer heavily employed which
improves metabolic efficiency, hence the drop in in glucose
uptake and increase oxygen uptake (Figure 5B). However,
beyond 50%, iJL1678-ME makes a trade-off between pro-
ducing more ETS, an expensive investment, to alternative
proteins (Figure 5C). This shift in protein expression to
accommodate the trade-off of ETS may play out similarly
for proteins not required for metabolism, protein trans-
location, or metabolite transport but are essential for other
processes (e.g., expression of flagella for locomotion).
Where do in vivo cells fall along this scan across inner
membrane occupancy? The calculated in vivo surface area
of 28.5%, based on RNA-seq data (Additional file 1), puts
a cell below optimal membrane occupancy. Within this
range of in vivo surface area, the increased acetate secre-
tion hints that membrane space constraints may indeed
be why cells employ combinatorial energy production
pathways at maximum growth rates, as Zhuang et al. had
hypothesized [6]. Furthermore, oxygen uptake drops
severely when the protein surface area approaches the
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in vivo value of 28.5% (17 mmol gDW−1 h−1 which is close
to the measured values of 15 mmol gDW−1 h−1 [69] and
18 mmol gDW−1 h−1 [70]). This finding implies that a
finite inner membrane protein surface area can limit the
oxygen uptake and usage rate, thereby lowering the growth
rate to less than the maximum potential.
Perturbations in network performance by changing
enzymatic efficiency
The Sec pathway is a key pharmaceutical target due to its
ubiquity and essentiality. For example, SecA is particularly
attractive since it does not have a human homologue, and
a recent non-cellular assay for SecA activity was devel-
oped specifically for drug discovery [71]. However, effects
of decreased Sec translocase activity on a cell are largely
unknown. While reactions in metabolic models can be
capped to mimic protein inhibition, iJL1678-ME takes this
ability further by targeting enzymatic efficiencies, similar
to the effects of drugs. Thus, the impact of inhibiting Sec
translocation on overall cellular phenotype was analyzed
with iJL1678-ME by targeting key enzymes. SecA is the
energy driver for the SecB/Sec pathway, and the ribosome
is the energy driver for the SRP pathway. Together, these
two pathways meet at SecYEGDF (Figure 1B). Due to their
importance, these three proteins were inhibited.
When the kcat values of SecA, SecYEGDF, and the
ribosome were reduced in a step-wise manner, growth rate
was affected differently in each situation (Figure 6A). The
relationship between ribosome inhibition and growth rate
is nearly linear. SecA and SecYEGDF, on the other hand,
behave in a hyperbolic manner. Thus, unlike ribosome,
the activity of SecA or SecYEGDF must be nearly elimi-
nated (i.e., SecA < 2.5%, SecYEGDF < 5%) to reduce the
growth rate by half. A closer look at these extremely low
enzymatic rates reveals that the in silico membrane prote-
ome was dominated by SecYEGDF. Therefore, membrane
occupancy was capped at 50%, as done by Zhuang et al.
[6], to determine whether spatial limitations may change
the overall behavior to Sec pathway perturbations. The
Figure 5 The effects of constraining the amount of membrane
surface area that may be occupied by protein. Shown here is a
scatterplot comparing the effects of controlled protein occupancy in
the membranes. (A) The effects of constraining the protein surface
area in the inner and outer membranes. The apex of growth rate
occurs at 0.42 fractional area for protein occupancy for the inner
membrane and 0.25 for the outer membrane. The growth rate
decreases more rapidly if membranes protein were under-produced
verses over-produced. (B) Acetate secretion, glucose uptake, and
oxygen uptake fluxes when constraining inner membrane protein
surface area. The gray solid bar represents the RNA-seq derived in vivo
surface area (+/− one standard deviation), and the dashed line
represents the optimal inner membrane surface area occupancy.
(C) Mass of the electron transport system complexes and glucose
transporters when constraining inner membrane protein surface area.
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inhibition simulations were repeated, showing that ribo-
some was not affected by membrane limitations, while
effects were observed when SecA and SecYEGDF’s turn-
over rates dropped below two amino acids per second
(Additional file 3: Figure S5). However, regardless of mem-
brane space, both SecA and SecYEGDF must be severely
inhibited to significantly decrease growth rate. This
example of targeting Sec translocation shows that iJL1678-
ME can be used to discover cellular effects of selected per-
turbations. Other molecular behaviors, like combinatorial
drug effects, may find similar answers through iJL1678-
ME. For example, simultaneously targeting the two
chaperone pathways for SecYEGDF, namely SecA and
ribosome, is not a synergistic approach, and SecA must still
be targeted for complete inhibition to significantly lower
the growth rate (Figure 6B).
Conclusions
Taken in whole, iJL1678-ME stoichiometrically represents
the wealth of knowledge known for protein translocation
of E. coli in an integrated and computable format. For the
first time, a bottom-up stoichiometric reconstruction (with
turnover rates) predicted protein levels without expression
data as inputs and imposed constraints. Furthermore, the
ability to explicitly model protein translocation and
compartmentalization of proteins is a significant advance-
ment for genome-scale models, as it alleviates the need for
fixed demands for the newly reconstructed content. In
combination with the membrane constraint, proteomic
predictions represent a milestone for constraint-based
modeling. As an example, iJL1678-ME could be utilized
for designing fine-tuned engineered strains by identifying
how the membrane proteome may react to overexpression
of non-cytoplasmic proteins and for determining ways to
counteract undesired effects through selective gene ma-
nipulation. Through exploration of modeled membrane
formation contextualized within protein translocation and
metabolism, iJL1678-ME demonstrated that bottom-up
systems-biology can be used to predict and analyze cellu-
lar physiology, thereby providing an opportunity to assist
and supplement research on fundamentally challenging
areas which may otherwise be difficult to study.
Improvements in iJL1678-ME are likely to come through
further experimental evidence. For example, more elucida-
tion is required on the exact stoichiometry of TatA pro-
teins per substrate and complex before such information
can be incorporated into iJL1678-ME. Other ME-model
based reconstructions may include a module to simulate
plasmid induction and subsequent protein secretion.
Finally, iJL1678-ME’s predictive capabilities could be im-
proved by incorporating data types such as ribosome pro-
filing, quantitative proteomics, and additional kcat values.
In conclusion, ME-models with compartmentalization
and membrane constraints open exciting new avenues for
the use of genome-scale models to interpret biological
functions, to form the basis for strain designs, and under-
stand infectious disease.
Methods
Reconstruction
A metabolism and gene expression model of E. coli, retro-
actively named here iOL1650-ME following an established
convention [8], was used as the starting basis on which
protein translocation reconstruction was built upon [7].
Literature review led to identification of five main
translocation pathways plus three alternate assisting
A) B)
Figure 6 The effects of inhibiting SecA on growth rate. (A) A scatterplot showing the effects of decreasing enzyme efficiency of several key
enzymes involved in Sec translocation (ATPase SecA, the channel SecYEGDF, and ribosome) have on growth rate. The growth rate was predicted
by decreasing turnover rate (i.e., kcat) of SecA, SecYEGDF, and ribosome and optimizing for growth rate. Simulations were performed with an
upper limit of 0.5 of the membrane protein surface area occupancy. (B) The effects of simultaneously inhibiting SecA and ribosome.
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proteins. These pathways were developed into template
reactions to which each of iJL1678-ME’s pORFs could
be applied to (Additional file 1).
Based on subcellular location annotations in Echoloca-
tion, EcoCyc and Uniprot (discrepancies and unknowns
settled through PSORTb and TMHMM), all pORFs and
protein complexes were assigned to one of four compart-
ments: Cytosol, inner membrane, periplasm, and outer
membrane [9,37-40]. The inner and outer membrane
compartments are new additions to iOL1650-ME. New
genes were also added to allow protein translocation and
lipoprotein biogenesis. Reactions in iOL1650-ME were
modified so that all proteins are compartmentalized.
Furthermore, reactions were curated to ensure that reac-
tions account for physical barrier membranes present. For
example, if a reaction involves metabolites located in the
cytoplasm and the periplasm, an inner membrane protein
must be present for the reaction to occur.
Proteins with known experimental evidence were
assigned to their respective translocase pathways. Based on
these known peptides and current hypotheses, a set of rules
was developed so that proteins without an experimentally-
validated pathway could be assigned to one. These rules
were established primarily by annotated subcellular location
and secondarily by the type of protein (Additional file 2:
Table S1). However, each pathway operates at its own
speed. iOL1650-ME’s coupling constraints offer a solution
for this problem, as the coupling constraints put limits on
fluxes by linking reactions to enzyme degradation and the
catalytic rate kcat (see Additional file 1 for basic formulation
and example) [7]. Using this established constraint, turn-
over rates were applied to the translocase pathways to im-
prove the model’s ability to predict the membrane
proteome (see Additional file 3: Figure S2 for translocation
without kcat). Key proteins of each pathway had calculated
turnover rates, and these kcat values were applied to all
other enzymes in the pathway that have an interaction with
that enzyme. The turnover rates of SecA, LolCDE, Bam,
and Tat were all known from literature while the turnover
rate for the SRP pathway was assumed to be equal to ribo-
some translation because of co-translational translocation
[42-46]. For Tat-translocated proteins, a best fit polynomial
equation for the number of TatA’s verses average channel
diameter was used to calculate the number of TatA’s re-
quired for each [23]. Protein diameter was calculated by
multiplying molecular weight by 1.21 to get volume and as-
suming a sphere shape [52]. Values were rounded up to the
nearest integer.
Lipoprotein biogenesis was also determined to be
relevant, and thus was included in the reconstruction
process. The model has the flexibility to choose fatty
acids from any available phospholipid. The proteins are
modified by Lgt, Lsp, and Lnt to become lipoproteins
(Additional file 1).
Murein demand was adapted from the original
iOL1650-ME model. However, since it is known that
45% of murein is recycled, the model is forced to utilize
the muropeptide transporter (AmpG), which has been
implicated in the process of murein recycling [50], so
that the flux of transported murein peptides is 45% of
the murein demand (0.01389 mmol gDW−1).
Outer membrane porins
As many as 2×105 porins have been determined to be in
the outer membrane [10]. Thus, to accurately account for
these pathways, the outer membrane porins were coupled
with diffusion rates [48,72,73]. In iJL1678-ME, the kcat
values of the outer membrane porins are individualized for
every combination of solute and porin, producing unique
reactions reflecting effective diffusion rates based on dia-
meters of solute and porin (Additional file 1, Additional
file 2: Table S4). To calculate the concentration difference
between the extra-cellular environment and the periplasm,
only porins with calculated effective diameters remained
in the model (Additional file 1). The diameters for all pos-
sible solutes were calculated using MarvinSketch assuming
(1) the solutes were suspended in water (solvent radius:
1.4 Å) and (2) the solvent accessible surface area was a
sphere, MarvinSketch 6.1.0, 2013, ChemAxon (http://www.
chemaxon.com). With all the values known and inputted,
this leaves the concentration difference between the extra-
cellular (Ce) and periplasm (Cp), Ce-Cp, as the sole variable.
Using an initial batch culture simulation in glucose M9
minimal media with the assumption Cp < < Ce, the total
flux of metabolite passage through outer membrane porins
was calculated. Using iJL1678-ME’s flux results of outer
membrane trafficking, the known number of porins (2×105
per cell) [10], the solute diffusion rate through porins, and
the porin constrain equations (Additional file 1), a series of
simulations with varying total solute concentration
differences were run to estimate the approximate differ-
ence to such that number of porins produced equals the
experimental value [74]. This concentration difference,
6.5×10−4 was incorporated into the porin diffusion rates
as the default value, which may be adjusted by the user.
Updating parameters
In order to determine how much more cellular mass
iJL1678-ME explicitly accounts for, RNA-seq was first
assumed to be a one-to-one proxy for protein expression
levels, and in this dataset, the new pORFs and outer mem-
brane proteins summed to 9.5% of all proteomic mass. As
a comparison point, the outer membrane protein mass,
i.e. lipoproteins and porins, was experimentally derived to
be 7.4% of total proteomic mass [10]. Supplementing 7.4%
with the estimated mass of protein translocases and lipo-
protein biogenesis proteins from RNA-seq (as there were
no experimental protein estimates available in literature)
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summed to 9.2% of total proteomic mass, which is similar
to 9.5%.
The GAM (growth associated maintenance) was up-
dated to account for the amount of ATP used in protein
translocation. The ATP flux used in protein translocation
by SecA and LolCDE was calculated and subtracted from
the GAM value established in iOL1650-ME, reducing it
from 35 to 34.98.
Membrane constraints
The combined surface area (SA) of membrane proteins,
phospholipids (PE is phosphatidylethanolamine, PG is
phosphatidylglycerol, and CLPN is cardiolipin), and lipo-
polysaccharides (LPS) must equal the total surface area
of a cell (equation 1) times four membrane leaflets
(equation 2) [54,75]. The surface area of each membrane
molecule was determined by its classification (Additional
file 2: Table S5). If the molecule was a protein, the pro-
tein was assumed to extend through the lipid bilayer and
occupy twice the amount of calculated surface area. An
additional constraint was imposed so that phospholipid
composition would better reflect the diversity of known
membranes (equation 3).
SA μð Þ ¼ 0:456π  2μ ln 2ð Þ3
 3:9  2μ ln 2ð Þ3 −0:456  2μ ln 2ð Þ3
 
þ 0:912π  2μ ln 2ð Þ3
 2
ð1Þ
4  SA μð Þ ¼
X
i ∈ proteins
SA of membraneproteini
þ
X
SA of LPS
þ
X
SA of phospholipids ð2Þ
X
SA of phospholipids ¼ 77% 
X
SAPE
þ 18% 
X
SAPG
þ 5% 
X
SACLPN ð3Þ
Additional constraints in the iJL1678-ME include a
variable maximum cap on protein surface area and the
option to force the model to produce nonfunctional
membrane protein.
This cell envelope demand for LPS and lipids originally
appearing in iOL1650-ME was removed, which makes the
production of these two types of molecules a function of
growth rate, protein production, and membrane size.
Membrane size was taken to growth-rate dependent as for-
mulated by O’Brien et al. (see [7] supplemental materials).
Analyzing the model
The model was run using batch simulations, as described
by O’Brien et al. using resources of the National Energy Re-
search Scientific Computing Center, which is supported by
the Office of Science of the U.S. Department of Energy
under Contract No. DE-AC0205CH11231 [7]. For all
analyses performed, the in silico media composition was
M9 and an excess of glucose (4 g L−1) (Additional file 2:
Table S6).
Since membrane proteomics is difficult to study; it is
even more difficult to obtain absolute numbers comparing
relative ratios of protein amounts. Therefore, RNA-seq
was used as an in vivo proxy for comparison (GEO acces-
sions: GSE48324 [58] and GSE61327 [59]). A 1:1 ratio of
protein expression levels to RNA-seq levels (FPKM nor-
malized to overall expression) was assumed. Mass was cal-
culated based on the atomic mass of the primary protein
structure multiplied by the flux of protein being produced.
In comparing in vivo data to in silico data, mass was
summed up by compartment location, functional annota-
tion, or both (Additional file 2: Table S2). Error bars are 1
standard deviation from two RNAseq runs.
The mass of compartmentalized functional annotations
between in vivo and in silico data was compared on a log-
log basis. A simple linear regression model was calculated
between the two datasets. The standardized residuals
(residual i / standard deviation of residual i) of the in silico
data was plotted against a rankit score (expected values of
the order statistics if the sample is normally distributed),
creating a normal probability plot. A line passing through
the first and third quartiles revealed points that deviated
from a normal distribution (i.e. deviated from the quartile
line). These points were removed from the dataset for
further analysis and the simple linear regression model was
recalculated for the reduced dataset.
Protein inhibition
To adjust the turnover rate of SecA, the coupling
constraint was modified so that it would reflect numbers
lower than the published value of 4.0 s−1 [43]. Similarly, all
coupling constraints involved with SecYEGDF or ribosome
were multiple by fractions to lower enzyme efficiencies. To
limit membrane inner membrane protein surface area, the
variable maximum cap (included as part of the membrane
constraint formulation) was set to 0.5.
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Additional file 1: Supplemental Methods. In-depth details describing
the methodology behind the reconstruction process.
Additional file 2: Supplemental Tables. Tables describing the changes
and numbers used during reconstruction compiled into a single excel
file. The table of contents is listed on the first sheet.
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Additional file 3: Supplemental Figures. Supplementary figures and
legends describing background analysis to accompany the figures in the
paper.
Additional file 4: iJL1678-ME. The iJL1678-ME model in python pickle
format along with sample python scripts and a README file to run a
simulation.
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